Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Through an Individualized Nutritionnal Approach and Semaglutide Therapy.
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs Semaglutide (Primary)
- Indications Fatty liver
- Focus Therapeutic Use
- Acronyms METAfoie
- 15 Jan 2025 New trial record